Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (221-230 of 275) with videos related to

Pageof 28
Sort By:
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
British Journal of Haematology|March 29, 2020
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trialChezi Ganzel, Xin V Wang, Jacob M Rowe, et al.
American Journal of Hematology|October 30, 2018
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult diseaseMark R Litzow, Xin V Wang, Martin P Carroll, et al.
Blood|June 12, 2010
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisVikas Gupta, Martin S Tallman, Wensheng He, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyZachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Blood|May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemiaCourtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Leukemia Research|October 30, 2012
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisAdi Diab, Lynette Zickl, Omar Abdel-Wahab, et al.
Pageof 28

Showing results (221-230 of 275) with videos related to

Sort By:
Pageof 28
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
British Journal of Haematology|March 29, 2020
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trialChezi Ganzel, Xin V Wang, Jacob M Rowe, et al.
American Journal of Hematology|October 30, 2018
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult diseaseMark R Litzow, Xin V Wang, Martin P Carroll, et al.
Blood|June 12, 2010
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisVikas Gupta, Martin S Tallman, Wensheng He, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyZachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Blood|May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemiaCourtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Leukemia Research|October 30, 2012
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisAdi Diab, Lynette Zickl, Omar Abdel-Wahab, et al.
Pageof 28